Skip to main content
Caplight Logo









Decibel Bio

Decibel Bio

Private
Berkeley, CaliforniaHealthcare & Life Scienceshttps://www.decibel.bio/

Last Round

Series A

Mar 5, 2025

Est. Valuation

$109M

Total Funding Raised

$246.7M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Decibel Bio is an agricultural biotechnology company that develops a proprietary platform to read and write the plant epigenome, enabling real-time trait enhancements for crops without altering their DNA.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

epigenetic reprogrammingagricultural biotechnologyagtechcrop performance managementepigenome-driven modelspredictive agronomic modelingfoliar sprayseed treatmentcrop resiliencebiotech R&Dprecision agricultureclimate adaptationsynthetic biologybio-engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Decibel Bio Comparables

Compare Decibel Bio with similar companies based on industry and business-model similarity.

Decibel Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Aferna Bio
80%
Epicrop Technologies
73%
Tropic Biosciences
71%

Decibel Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 5, 2025
M&ASep 25, 2023
IPOFeb 11, 2021
Series DNov 9, 2020
Series CJun 19, 2018
Series B
Nov 15, 2017

Key People

Founding team and executive leadership

Travis Bayer

Chief Executive Officer

Executive Team

Decibel Bio Investors

Notable investors and investment history

Decibel Bio investors
InvestorRounds
Surveyor CapitalSeries D
Janus Henderson GroupSeries D
Fall Line CapitalSeries A
Future VenturesSeries A
GVSeries C, Series B, Series D
OrbiMedSeries D
Breakthrough Energy VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors grew 388% MoM, from 315 to 1.5K.

  • Apr 20, 2026

    Monthly visitors increased 55% MoM.

Decibel Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Decibel Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Decibel Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersBerkeley, California
Employee Range12
Year Founded2025
Last FundingMar 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?